You are here

  • Home
  • Archive
  • Volume 15, Issue 5
  • Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies

Article metrics

Article menu
Download PDFPDF
Original Article
Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies

 

Online download statistics by month:

Online download statistics by month: February 2019 to April 2024

AbstractFullPdf
Feb 20191301
Mar 2019600
Apr 2019800
May 20191600
Jun 2019600
Jul 2019900
Aug 20191000
Sep 20193001
Oct 2019801
Nov 2019400
Dec 20191500
Jan 20201700
Feb 2020601
Mar 2020800
Apr 20201201
May 20202302
Jun 2020600
Jul 20201200
Aug 2020800
Sep 20201001
Oct 2020800
Nov 2020101
Dec 20201400
Jan 2021200
Mar 20211701
Apr 2021100
May 2021100
Jul 2021100
Aug 2021100
Sep 2021300
Oct 2021800
Nov 20211200
Dec 2021600
Jan 20221800
Feb 20221600
Mar 20221101
Apr 20221701
May 20224102
Jun 20223001
Jul 20221000
Aug 20222800
Sep 20224202
Oct 20225600
Nov 20222300
Dec 20221000
Jan 2023501
Feb 20235000
Mar 20231403
May 2023400
Jun 2023803
Jul 2023803
Aug 20231903
Sep 2023901
Oct 20231000
Nov 2023400
Dec 20232101
Jan 20241000
Feb 20242301
Mar 2024901
Apr 20241400
Total812034